Clinical Observation on Advanced Pancreatic Cancer Treated by Yiqi Huoxue Decoction Combined with Gemcitabine Arterial Perfusion
- VernacularTitle:益气活血中药联合吉西他滨动脉灌注治疗晚期胰腺癌临床观察
- Author:
Qing ZHANG
;
Dong HAN
;
Huichang CHI
- Publication Type:Journal Article
- Keywords:
Yiqi Huoxue decoction;
Gemcitabine;
arterial perfusion;
advanced pancreatic cancer
- From:
Chinese Journal of Information on Traditional Chinese Medicine
2006;0(08):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect of Yiqi Huoxue decoction combined with chemical arterial perfusion in treating advanced pancreatic cancer. Methods Review the clinical effect and benefit response of Yiqi Huoxue decoction combined with chemicals (Gemcitabine+PDD) arterial perfusion in treating 43 cases of advanced pancreatic cancer. Results The objective response rate (CR+PR) in treated group was 25.6%. The clinical benefit response rate (CR+PR+NC) in treated group was 67.4%,and the clinical benefits were mainly in the aspects of pain extent and quality of life. The rate of relief from pain was 74.3%. Conclusion The effect of Yiqi Huoxue decoction combined with chemicals (Gemcitabine+PDD) arterial perfusion in treating advanced pancreatic cancer was reliable,and the clinical benefit response was good.